Helix Biopharma Corp HBPCF:Grey Market

RT Quote | Exchange | USD
Last | 03/03/21 EST
0.7089UNCH (UNCH)
52 week range
0.22 - 1.15

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7089
  • 52 Week High1.15
  • 52 Week High Date04/17/20
  • 52 Week Low0.22
  • 52 Week Low Date12/28/20
  • Market Cap81.04M
  • Shares Out132.93M
  • 10 Day Average Volume2,791.29
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-13.91
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Helix Biopharma Corp News

There is no recent news for this security.

Latest HBPCF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein...
Slawomir Majewski M.D.
Chairman
Heman Chao Ph.D.
Chief Executive Officer
Photios Michalargias CPA
Chief Financial Officer
Address
9120 Leslie St Suite 205
Richmond Hill, ON
L4B 3J9
Canada